このページの翻訳は実験的なもので、現在開発中です。お待ちしております
Ardelyx マネジメント
マネジメント 基準チェック /34
Ardelyx'sの CEO はMike Raabで、 Mar2009年に任命され、 の在任期間は 15.25年です。 の年間総報酬は$ 4.12Mで、 17%給与と83%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の0.55%を直接所有しており、その価値は$ 8.15M 。経営陣と取締役会の平均在任期間はそれぞれ4年と8.3年です。
主要情報
Mike Raab
最高経営責任者
US$4.1m
報酬総額
| CEO給与比率 | 17.0% |
| CEO在任期間 | 15.5yrs |
| CEOの所有権 | 0.5% |
| 経営陣の平均在職期間 | 4.3yrs |
| 取締役会の平均在任期間 | 8.9yrs |
経営陣の近況
Recent updates
Is Ardelyx (NASDAQ:ARDX) Weighed On By Its Debt Load?
Aug 25
Party Time: Brokers Just Made Major Increases To Their Ardelyx, Inc. (NASDAQ:ARDX) Earnings Forecasts
Aug 07Ardelyx Faces Rising Challenges Despite Revenue Growth
Aug 05Earnings Beat: Ardelyx, Inc. (NASDAQ:ARDX) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
Aug 04Ardelyx: Increased Focus On Ibsrela Due To Xphozah's Uncertain Outlook
Jul 13Why Investors Shouldn't Be Surprised By Ardelyx, Inc.'s (NASDAQ:ARDX) 25% Share Price Plunge
Jul 05Ardelyx: Strong Execution, Fairly Valued
May 10Ardelyx, Inc. (NASDAQ:ARDX) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates
May 04Ardelyx Stock: A Crowded Market Curbs The Enthusiasm (Rating Downgrade)
May 03Ardelyx, Inc.'s (NASDAQ:ARDX) Popularity With Investors Is Under Threat From Overpricing
Apr 17Ardelyx Shrugs Off 'Mixed' Q4 Earnings
Mar 13Earnings Update: Ardelyx, Inc. (NASDAQ:ARDX) Just Reported Its Yearly Results And Analysts Are Updating Their Forecasts
Feb 24Ardelyx Q4 Preview: Recent Bull Run May Pause While Market Digests 2024 Guidance
Feb 20Ardelyx's XPHOZAH Still An Afterthought To The Pros
Jan 31Ardelyx: FDA Approval For Xphozah Grants Further Sales Enhancement
Jan 10Ardelyx, Inc.'s (NASDAQ:ARDX) Business Is Yet to Catch Up With Its Share Price
Jan 04Despite Lacking Profits Ardelyx (NASDAQ:ARDX) Seems To Be On Top Of Its Debt
Dec 14Party Time: Brokers Just Made Major Increases To Their Ardelyx, Inc. (NASDAQ:ARDX) Earnings Forecasts
Aug 03Rock star Growth Puts Ardelyx (NASDAQ:ARDX) In A Position To Use Debt
Jul 31Pinning Down Ardelyx, Inc.'s (NASDAQ:ARDX) P/S Is Difficult Right Now
Apr 17Is Ardelyx (NASDAQ:ARDX) Using Debt Sensibly?
Mar 30Is Ardelyx (NASDAQ:ARDX) Using Debt Sensibly?
Dec 14What To Expect For Ardelyx In The Coming Month
Oct 18Ardelyx: Potential For Growth, But Must Strengthen Its Financial Position
Oct 04Ardelyx secures $20M financial deal with HealthCare Royalty on tenapanor potential sale
Jun 30CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$65m |
| Mar 31 2024 | n/a | n/a | -US$66m |
| Dec 31 2023 | US$4m | US$700k | -US$66m |
| Sep 30 2023 | n/a | n/a | -US$27m |
| Jun 30 2023 | n/a | n/a | -US$56m |
| Mar 31 2023 | n/a | n/a | -US$66m |
| Dec 31 2022 | US$2m | US$650k | -US$67m |
| Sep 30 2022 | n/a | n/a | -US$114m |
| Jun 30 2022 | n/a | n/a | -US$135m |
| Mar 31 2022 | n/a | n/a | -US$153m |
| Dec 31 2021 | US$4m | US$650k | -US$158m |
| Sep 30 2021 | n/a | n/a | -US$151m |
| Jun 30 2021 | n/a | n/a | -US$125m |
| Mar 31 2021 | n/a | n/a | -US$105m |
| Dec 31 2020 | US$4m | US$633k | -US$94m |
| Sep 30 2020 | n/a | n/a | -US$85m |
| Jun 30 2020 | n/a | n/a | -US$91m |
| Mar 31 2020 | n/a | n/a | -US$91m |
| Dec 31 2019 | US$2m | US$595k | -US$95m |
| Sep 30 2019 | n/a | n/a | -US$103m |
| Jun 30 2019 | n/a | n/a | -US$104m |
| Mar 31 2019 | n/a | n/a | -US$100m |
| Dec 31 2018 | US$4m | US$575k | -US$91m |
| Sep 30 2018 | n/a | n/a | -US$53m |
| Jun 30 2018 | n/a | n/a | -US$50m |
| Mar 31 2018 | n/a | n/a | -US$53m |
| Dec 31 2017 | US$5m | US$555k | -US$64m |
報酬と市場: Mikeの 総報酬 ($USD 4.12M ) は、 US市場 ($USD 5.67M ) の同様の規模の企業の平均とほぼ同じです。
報酬と収益: Mikeの報酬は増加しましたが、会社は利益を上げていません。
CEO（最高経営責任者
Mike Raab (59 yo)
15.5yrs
在職期間
US$4,118,144
報酬
Mr. Michael G. Raab, also known as Mike, has been the Chief Executive Officer and President of Ardelyx, Inc. since March 2009. He is a Director of Tempest Therapeutics Inc. since May 2019 and its Chairman...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| President | 15.5yrs | US$4.12m | 0.53% $ 7.6m | |
| Chief Legal & Administrative Officer and Secretary | 10.3yrs | US$1.63m | 0.082% $ 1.2m | |
| Chief Medical Officer | 3.8yrs | US$1.63m | 0.13% $ 1.9m | |
| Chief Financial & Operations Officer | 4.3yrs | US$1.73m | 0.13% $ 1.8m | |
| Senior VP of Finance & Chief Accounting Officer | 2.5yrs | データなし | 0.039% $ 561.3k | |
| Vice President of Corporate Communications & Investor Relations | no data | データなし | データなし | |
| Executive Vice President of Corporate Development & Strategy | less than a year | データなし | データなし | |
| Chief Human Resources Officer | 1.7yrs | データなし | データなし | |
| Chief Development Officer | 9.7yrs | US$1.63m | 0.25% $ 3.6m | |
| Chief Regulatory Affairs & Quality Assurance Officer | no data | US$1.70m | 0.14% $ 2.0m | |
| Advisor | 4.3yrs | US$1.04m | 0.19% $ 2.8m | |
| Manager of Corporate Communications & Investor Relations | no data | データなし | データなし |
4.3yrs
平均在職期間
60yo
平均年齢
経験豊富な経営陣: ARDXの経営陣は 経験豊富 であると考えられます ( 4年の平均在職年数)。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| President | 15.5yrs | US$4.12m | 0.53% $ 7.6m | |
| Independent Chairman of the Board | 15.5yrs | US$249.90k | 0.51% $ 7.4m | |
| Independent Director | 8.9yrs | US$214.90k | 0.098% $ 1.4m | |
| Independent Director | 10.5yrs | US$222.40k | 0.11% $ 1.5m | |
| Independent Director | 8.3yrs | US$202.40k | データなし | |
| Independent Director | 4.5yrs | US$199.90k | 0.047% $ 675.3k | |
| Independent Director | 3.5yrs | US$202.40k | 0.041% $ 587.2k |
8.9yrs
平均在職期間
59yo
平均年齢
経験豊富なボード: ARDXの 取締役会 は 経験豊富 であると考えられます ( 8.3年の平均在任期間)。